Accurately detect HPV infection. Help prevent cervical cancer. Reliable detection of high-risk HPV DNA with genotyping of HPV 16 and 18/45 In Vitro Diagnostic Medical Device

High-risk human papillomavirus (HPV) testing is a highly effective and reliable method of screening to prevent cervical cancer. An easy-to-use, rapid (~60 minutes to results), and scalable (1 to 80 tests per hour) HPV test with partial genotyping for the most important HPV types (HPV16 and HPV18/45) for risk stratification is transformative. It now will be possible to deploy centralized or point-of-care HPV testing for cervical cancer screening in all settings throughout the world using a wide range of clinical algorithms, including same-day screen-and-treat strategies.” Philip E. Castle, Ph.D.,...

© THE IMPACT Improve your laboratory workflow with simple, on-demand, random-access flexibility. Combine performance with the ability to run other tests (such as CT/NG, TV, HIV, HCV, and GBS) on the GeneXpert® System to achieve a proven increase in overall laboratory level service. Shift from reactive to proactive • Improved patient care: risk stratification in less than 60 minutes to support better clinical decisions. • Full ownership of patient results with same day cytology and HPV testing. • Optimal assay design for improved accuracy and reproducibility. • Adaptable: remote, near patient,...

WORKFLOW: 2 Easy Steps Total hands-on time: <1 minute * 1 Transfer 1 ml of appropriately collected cervical specimen to the cartridge*. System Throughput8-hr shift 16 GX-II References: 1. de Sanjose S, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010 Nov;11(11):1048-56. 2. Cox JT, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the Athena HPV study. Am J Obstet Gynecol. 2013 Mar;208(3):184.e1-184.e11....